Trials / Conditions / Epidermolysis Bullosa Dystrophica, Recessive

Epidermolysis Bullosa Dystrophica, Recessive

7 registered clinical trials studyying Epidermolysis Bullosa Dystrophica, Recessive — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment NCT07193134	CHU de Quebec-Universite Laval	Phase 1 / Phase 2
Recruiting	A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) NCT06563414	Krystal Biotech, Inc.	—
Active Not Recruiting	Ex Vivo Gene Therapy Clinical Trial for RDEB Using Genetically Corrected Autologous Skin Equivalent Grafts NCT04186650	Institut National de la Santé Et de la Recherche Médicale, France	Phase 1 / Phase 2
Terminated	A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Saf NCT03605069	Phoenicis Therapeutics	Phase 1 / Phase 2
Unknown	Safety Study and Preliminary Efficacy of Infusion Haploidentical Mesenchymal Stem Cells Derived From Bone Marr NCT04153630	Instituto de Investigación Hospital Universitario La Paz	Phase 1 / Phase 2
Terminated	A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) NCT02810951	Castle Creek Biosciences, LLC.	Phase 1 / Phase 2
Unknown	A Comparative Study of the Healing of Chronic Ulcers of Recessive Epidermolysis Bullosa : Dressing vs Amniotic NCT02286427	Assistance Publique - Hôpitaux de Paris	Phase 3